Commentary: Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy

Commentary: Blockade of activin type II receptors with a dual anti-ActRIIA/IIB antibody is critical to promote maximal skeletal muscle hypertrophy

Bibliographic Details
Main Authors: Javier Durán, Manuel Estrada
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-04-01
Series:Frontiers in Pharmacology
Subjects:
bimagrumab
ActRIIA/B receptors
skeletal muscle
anabolic steroids
myostatin/activin
Online Access:http://journal.frontiersin.org/article/10.3389/fphar.2018.00381/full

Similar Items

Similar Items